Clinical Trial Update: Maxi-Analgesic Osteoarthritis (OA) Study [Phase 3]

View source ↗

Summary

The Phase 3 Maxi-Analgesic Osteoarthritis trial has been withdrawn from development. The sponsor is AFT Pharmaceuticals, Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• Maxi-Analgesic

Snippet

Sponsor: AFT Pharmaceuticals, Ltd. | Conditions: Osteoarthritis | Phase 3 | Status: WITHDRAWN